Identification of Patients With High Probability of Not or Poorly Responding to Mycophenolate-mofetil (Cellcept) or Mycophenolate-natrium (Myfortic) Therapy.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Mycophenolate mofetil; Mycophenolate sodium
- Indications Renal transplant rejection
- Focus Pharmacogenomic; Therapeutic Use
- 23 Apr 2012 Actual initiation date (October 2009) added as reported by ClinicalTrials.gov.
- 23 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Sep 2009 New trial record